Inflammatory response and cytokine levels induced by intralesional photodynamic therapy and 630-nm laser in a case series of basal cell carcinoma To the Editor: Topical photodynamic therapy (PDT) is an alternative treatment for basal cell carcinoma (BCC), but its main limitation is the poor penetration inside the tissue. We have previously reported a high initial cure rate (100%) 1 and a maintenance of response in 6 years of follow-up (93.75%) 2 in nodular BCC treated with intralesional PDT (I-PDT). BCC, Basal cell carcinoma; IL, interleukin; SD, standard deviation; T0, baseline time point; T1, time point after incubation with photosensitizer; T2, time point after irradiation; TNF, tumor necrosis factor. *Limits of detection of cytokines were 7.2 pg/mL for IL-1, 2.5 pg/mL for IL-6, 3.6 pg/mL for IL-8, 3.3 pg/mL for IL-10, 1.9 pg/mL for IL-12p70, and 3.7 pg/mL for TNF.
In order to understand the mechanism of action of the technique, we analyzed the changes in the intralesional inflammatory cytokines pattern in a series of 18 BCC patients treated with I-PDT. After intralesional anaesthesia with mepivacaine, a lyophilized 5-aminolevulinic acid (5-ALA) 1% (0.2 mL/cm 2 ) was injected inside the tumor and incubated for 120 minutes. Then, the tumor was intralesionally irradiated with a 630-nm laser beam through a fiber optic probe of 400 m ( power 1 W and fluence 180 J/cm 2 ). All patients achieved tumor resolution after 1 or 2 sessions (16 and 2 patients, respectively), histologically confirmed by a punch biopsy in the area treated. This confirmation was made at 3 months of treatment, finding only fibrosis or scarring in the biopsy sample. To study the I-PDTeinduced inflammatory response, intralesional exudates were collected with a heparinized capillary tube at baseline (T0), after 5-ALA incubation (T1), and immediately after irradiation (T2). Samples were later analyzed in a single assay for inflammatory cytokines interleukin (IL) 1, IL-6, IL-8, IL-10, IL1-2p70, and tumor necrosis factor (TNF) by flow cytometry (FACScanto, BD Biosciences, Franklin Lakes, NJ) using the Cytometric Bead Array (CBA) Human Inflammatory Cytokine Kit (BD Biosciences) according to the manufacturer's instructions. Statistical analysis was completed by using SPPS Statistics 22.0 (IBM Corp, Arkmon, NY). Fig 1. A, IL levels at baseline (T0) and after treatment with intralesional photodynamic therapy (I-PDT) (T2). The Wilcoxon test was used for statistical analysis, and whiskers indicated standard deviation. Mean cytokine levels of IL-6, IL-1, and IL-8 were significantly increased after injection with photosensitizer and irradiation (T2) in comparison with before treatment. After I-PDT, IL-6 and IL-8 levels increased in 17 of 18 patients and IL-1 in 16 of 18 patients. Mean values of IL-6, IL-1, and IL-8 were significantly higher after I-PDT (P \ .0001, P ¼ .0046, and P \ .0001, respectively). B, IL level by location (nose, lip, and check) and number of sessions needed to achieve complete tumor clearance. P values (Wilcoxon) for the differences in the IL-6, IL-8, and IL-1ß levels in paired samples from the nose for the T1 versus T0 time points were 0.043, 0.028, and 0.046, respectively, and for the T2 versus T0 time points 0.01, 0.07, and 0.028, respectively. P values were [0.05 for lip and check samples. IL, Interleukin.
Patient data, treatment conditions, and clinical and immune responses are shown in Table I . As shown in Fig 1, A , mean values of IL-6, IL-1, and IL-8 were significantly higher after I-PDT.
The data indicated a consistent inflammatory response in patients with BCC treated by I-PDT. We believe that our data provides greater clarity on the role of the immune system during PDT and reveals information about the mechanism of action of the technique. Intravenous ALA plus PDT has been described to induce TNF-, IL-10, and IL-6, with IL-6 acting as the key inflammatory cytokine involved in the antitumoral immune response. 3 However, in healthy skin treated with topical ALA plus PDT, TNF-has been described as the driving inflammatory chemotactic factor in inflammationassociated cell dynamics. 3 We did not find any changes in TNF-or IL-10 levels. However, IL-1, IL-8, and IL-6 increased in all patients, suggesting a different inflammatory response pattern. We speculate that different inflammatory mediators might induce different leukocyte migration and differentiation patterns responsible for the longer clinical response with I-PDT, 2 or the clinical response to I-PDT could be related to the increased accumulation of protoporphyrin IX in dormant cancer cells 4 because the injected photosensitizer is able to reach the deepest skin layers. 5 In our study, increased levels of IL-8, IL-1, and IL-6 were achieved at T1, even before irradiation.
In summary, increased IL-1ß, IL-6, and IL-8 levels were achieved after I-PDT. Future research should aim to identify the subsequent immune response stimulated and specific activated cells involved in this process. 
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